Skip to content

Effectiveness of Combined Transcranial Direct current Stimulation (tDCS) with Pharmacotherapy and Pharmacotherapy in Bipolar Disorders

Comparison of the Effectiveness of Combined Transcranial Direct Current Stimulation (tDCS) with Pharmacotherapy and Pharmacotherapy on Depression, Emotion Regulation, Response Inhibition, Problem Solving in Patients with Bipolar Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191229045931N1
Enrollment
30
Registered
2020-08-24
Start date
2020-01-21
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

It is a bipolar disorder. Bipolar disorder, current episode depressed, severe, without psychotic features

Interventions

Intervention 1: Intervention Group: Combination of tDCS and medication:The tDCS treatment program was performed for 10 sessions of 20 minutes (F3) and (F4) for the experimental group. The electric cur

Sponsors

Deputy of Research and Research Zanjan University of Medical Sciences.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Type 1 bipolar disorder at the discretion of a psychiatrist Willingness to participate in research Age range minimum 18 and maximum 50 years At least third grade education No severe psychiatric disorders such as psychotic disorders and cognitive impairment Lack of history of epileptic seizures and history of head injury Failure to receive psychological and technological therapies at least one month before entering the study

Exclusion criteria

Exclusion criteria: Severe psychiatric disorders such as psychotic disorders and cognitive impairment History of epileptic seizures and history of head injury Consumption of drugs and alcohol Existence of suicidal thoughts Existence of rapid cycles of mania

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: 10 day and 3 month. Method of measurement: Hamilton Depression Scale.;Emotion Regulation. Timepoint: 10 day and 3 month. Method of measurement: Grass emotion regulation questionnaire.;Response Inhibition. Timepoint: 10 day and 3 month. Method of measurement: GO no GO test.;Problem Solving. Timepoint: 10 day and 3 month. Method of measurement: the tower of London.

Secondary

MeasureTime frame
Impulsivity. Timepoint: 10 day and 3 month. Method of measurement: The Bart impulsivity scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Elnaz Mousavi

Zanjan University of Medical Sciences

Dr.Emousavi@zums.ac.ir+98 24 3353 4500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 14, 2026